**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 1335-32-6 |Lead subacetate | ca.100 | 215-630-3 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T
Risk Phrases: 33 40 48/22 61 62
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Danger of cumulative effects. Limited evidence of a carcinogenic
effect. Harmful : danger of serious damage to health by prolonged
exposure if swallowed. May cause harm to the unborn child. Possible
risk of impaired fertility.Air sensitive.
Potential Health Effects
Eye:
Causes eye irritation. Causes redness and pain.
Skin:
Causes skin irritation. May be absorbed through the skin in harmful
amounts. Causes redness and pain. If absorbed, may cause symptoms
similar to those for ingestion.
Ingestion:
Harmful if swallowed. May cause severe and permanent damage to the
digestive tract. May cause severe digestive tract irritation with
abdominal pain, nausea, vomiting and diarrhea. Ingestion of lead
compounds can cause toxic effects in the blood-forming organs,
kidneys and central nervous system. Acute lead poisoning can cause
muscle weakness, "lead line" on the gums, metallic taste, definite
loss of appetite, insomnia, dizziness, high lead levels in blood and
urine with shock, coma and death in extreme cases.
Inhalation:
May cause respiratory tract irritation. May cause effects similar to
those described for ingestion.
Chronic:
Possible cancer hazard based on tests with laboratory animals.
Chronic inhalation and ingestion may cause effects similar to those
of acute inhalation and ingestion. Chronic exposure to lead may
result in plumbism which is characterized by lead line in gum,
headache, muscle weakness, mental changes. Lead salts have been
reported to cross the placenta and induce embryo- and feto-
mortality. Chronic expsoure to lead may cause adverse effects on
human reproduction, embryonic and fetal development and postnatal
(e.g., mental) development.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4
cupfuls of milk or water. Never give anything by mouth to an
unconscious person. Get medical aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively. Persons with pre-existing
kidney, nerve or circulatory disorders or with skin or eye problems
may be more susceptible to the effects of this substance.
Antidote:
The use of d-Penicillamine as a chelating agent should be determined
by qualified medical personnel. The use of Dimercaprol or BAL
(British Anti-Lewisite) as a chelating agent should be determined by
qualified medical personnel.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Dust can be an explosion hazard when exposed to
heat or flame.
Extinguishing Media:
Use extinguishing media most appropriate for the surrounding fire.
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Avoid runoff into storm sewers and ditches which lead to
waterways. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation. Place under an inert atmosphere.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use only in a well-ventilated area. Avoid contact
with eyes, skin, and clothing. Avoid ingestion and inhalation.
Handle under an inert atmosphere. Store protected from air.
Storage:
Store in a tightly closed container. Keep from contact with
oxidizing materials. Store in a cool, dry, well-ventilated area away
from incompatible substances. Do not expose to air. Store under an
inert atmosphere.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective clothing to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant a respirator's use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: white
Odor: odorless
pH: Not available.
Vapor Pressure: Negligible.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Soluble in cold water.
Specific Gravity/Density:
Molecular Formula: C4H8O6Pb2
Molecular Weight: 566.50
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures. Air sensitive.
Conditions to Avoid:
Incompatible materials, dust generation, exposure to air, excess
heat, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong acids, acids, active metals,
bromates, phenols, potassium, hydrogen peroxides, sodium, sulfides
(inorganic, e.g. ferric sulfide, lead sulfide, sodium sulfide),
sulfites, phosphates, carbonates, chloral hydrate, alkalis,
resorcinol, tannin, air, salicylic acid, vegetable infusions,
citrates, chlorides, tartrates.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon
dioxide, lead/lead oxides.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 1335-32-6: OF8750000
LD50/LC50:
Not available.
Carcinogenicity:
Lead subacetate -
California: carcinogen, initial date 10/1/89
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: LEAD COMPOUND, SOLUBLE, N.O.S.
Hazard Class: 6.1
UN Number: 2291
Packing Group: III
IMO
Shipping Name: LEAD COMPOUND, SOLUBLE, N.O.S.
Hazard Class: 6.1
UN Number: 2291
Packing Group: III
RID/ADR
Shipping Name: LEAD COMPOUND, SOLUBLE, N.O.S.
Hazard Class: 6.1
UN Number: 2291
Packing group: III
USA RQ:CAS# 1335-32-6: 10 lb final RQ; 4.54 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 61 May cause harm to the unborn child.
R 33 Danger of cumulative effects.
R 40 Limited evidence of a carcinogenic effect.
R 48/22 Harmful : danger of serious damage to health
by prolonged exposure if swallowed.
R 62 Possible risk of impaired fertility.
Safety Phrases:
S 53 Avoid exposure - obtain special instructions
before use.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 1335-32-6: No information available.
United Kingdom Occupational Exposure Limits
United Kingdom Maximum Exposure Limits
CAS# 1335-32-6: MEL-United Kingdom, TWA (listed as ** undefined
**): 0.15 mg/m3 TWA (except lead alkyls - see CLAW regulations)
Canada
CAS# 1335-32-6 is listed on Canada's DSL List.
CAS# 1335-32-6 is listed on Canada's Ingredient Disclosure List.
Exposure Limits
CAS# 1335-32-6: Not available.
US FEDERAL
TSCA
CAS# 1335-32-6 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 6/29/1999 Revision #3 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|